We serve Alkylphenol disulfide CAS:25085-50-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Light yellow solid | Conform |
| Softening point | 85-130℃ | 105℃ |
| Methylol Content | 9-20% | 18% |
| Liposolubility (1:2Tung oil,240℃） |
Total Soluble | Conform |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like Alkylphenol disulfide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,formaldehyde – 4-tert-butylphenol (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Formaldehyde, compd. with 4-(1,1-dimethylethyl)phenol (1:1) Use and application,formaldehyde – 4-tert-butylphenol (1:1) technical grade,usp/ep/jp grade.
Related News: In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.2-(4-methyl-piperazin-1-yl)-4-(1-oxo-1λ4-thiomorpholin-4-yl)-quinazolin-7-ylamine manufacturer In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.Chlorphenesin supplier Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs.O-Benzyl-N-(benzyloxycarbonyl)-DL-serin-methyl ester vendor This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.
